Pharmaboardroom.com: Interview with ARCHIMEDlife CEO David Kasper in Austria issue of “Healthcare and Life Sciences Review”

16. Oktober 2017

Pharmaboardroom.com interviewed ARCHIMEDlife CEO David Kasper for their latest Austria issue of „Healthcare and Life Sciences Review”. Find out...

Read more

ARCHIMEDlife @ MSACL Salzburg: Mass Spectrometry Applications to Clinical Lab, 10.- 4.9.17

13. September 2017

We are proud to be a regular part of MSACL –  this year in Salzburg from 10.- 14. September...

Read more

Become part of our readers´ community

4. September 2017

You can easily subscribe to our monthly ARCHIMEDlife Newsletter and read about laboratory diagnostics, research studies, scientific publications and...

Read more

Genotype, phenotype and disease severity reflected by serum LysoGb3 levels in patients with Fabry disease

5. Juli 2017

Background: Fabry disease (FD) is a rare X-linked lysosomal storage disease caused by mutations in the α-galactosidase A (GLA)...

Read more

Detect Severe combined immunodeficiency (SCID) early at birth!

21. Juni 2017

We offer TREC (T-cell receptor excision circle) DNA testing from Dried Blood Spots to aid in screening newborns for...

Read more

Correlation of Lyso-Gb3 levels in dried blood spots and sera from patients with classic and Later-Onset Fabry disease

16. Juni 2017

Background: Fabry disease (FD), an X-linked lysosomal storage disorder, results from the deficient activity of α-galactosidase A (α-Gal A)...

Read more

Metabolic progression to clinical phenotype in classic Fabry disease

3. Januar 2017

Background: Fabry disease is an X-linked lysosomal storage disorder due to α-galactosidase A (α-Gal A) deficiency. Clinical onset of...

Read more

Plasma LysoGb3: A useful biomarker for the diagnosis and treatment of Fabry disease heterozygotes

19. Oktober 2016

Background: Fabry disease (FD) is a rare X-linked lysosomal storage disorder due to mutations in the a-galactosidase A gene (GLA)...

Read more

Upcoming expanded Testing for Lysosomal Storage Disorders

21. September 2016

ARCHIMEDlife started offering genetic testing for Gaucher, Niemann-Pick A/B, MPS-I, Pompe and Fabry disease. More recently, we expanded our...

Read more